Cooperative Research and Development Agreement (CRADA) at
Links and Resources
Authority
- Federal Technology Transfer Act, 15 USC § 3710a and Executive Order 12591 of April 10, 1987
Description
A Cooperative Research and Development Agreement (CRADA) is an agreement between NIH laboratories or centers and at least one other party toward the conduct of specified research or development efforts that are consistent to the missions of the laboratory.
A CRADA is used when the partner requests intellectual property rights.
A CRADA is used when a partner provides a nonavailable material to the NIH and requests the transfer of intellectual property rights in the result of associated research.
Features/Characteristics
The Federal Technology Transfer Act provides for a 30-day period in which to disapprove or modify a CRADA after its finalization.
An Interim Letter of Intent may be required./p>
A CRADA is used when a cooperative R&D project between the NIH and a scientist from the private sector is contemplated; when the exchange of material and/or research and development collaboration takes place over a substantial period of time; when staff or equipment is to be supplied by one or more parties; or when the industrial partner contributes funding or requests the granting of intellectual property rights.
Types:
- Basic Research CRADA
- Specialized Materials CRADA
- Clinical Trial CRADA
I.P. and Resource Commitment
NIH provides in-kind such as facilities, resources, personnel, etc. No funds are exchanged with nonfederal entities.
The collaborating party provides funds, resources, facilities, etc.
Any IP and licensing rights that result from the CRADA are negotiated; only mechanisms used by NIH to negotiate IP rights in advance.
The government retains rights to an exclusive license of any intellectual property that results from the CRADA.
Other Agencies/Laboratories That Use This Mechanism
